Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Steele

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 9, 2022
Encephalitis in adults in the Auckland and Northland regions of New Zealand, 2009 to 2018Bernard Liem, Neil E Anderson, Sarah L Wright, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Reviews in Allergy & Immunology|October 15, 2017
Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome SequencingRohan Ameratunga, Klaus Lehnert, See-Tarn Woon, et al.
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
The New Zealand Medical Journal|April 9, 2008
The changing epidemiology of food allergy--implications for New ZealandChristine Crooks, Rohan Ameratunga, Greg Simmons, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 9, 2022
Encephalitis in adults in the Auckland and Northland regions of New Zealand, 2009 to 2018Bernard Liem, Neil E Anderson, Sarah L Wright, et al.
Frontiers in Immunology|February 14, 2018
Clinical Implications of Digenic Inheritance and Epistasis in Primary Immunodeficiency DisordersRohan Ameratunga, See-Tarn Woon, Vanessa L Bryant, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Reviews in Allergy & Immunology|October 15, 2017
Review: Diagnosing Common Variable Immunodeficiency Disorder in the Era of Genome SequencingRohan Ameratunga, Klaus Lehnert, See-Tarn Woon, et al.
Frontiers in Immunology|October 14, 2014
Comparison of diagnostic criteria for common variable immunodeficiency disorderRohan Ameratunga, Maia Brewerton, Charlotte Slade, et al.
The New Zealand Medical Journal|April 9, 2008
The changing epidemiology of food allergy--implications for New ZealandChristine Crooks, Rohan Ameratunga, Greg Simmons, et al.
Antiviral Research|April 27, 2024
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?Rohan Ameratunga, Anthony Jordan, Klaus Lehnert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
Frontiers in Immunology|February 4, 2022
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised PatientsRohan Ameratunga, See-Tarn Woon, Richard Steele, et al.
Pageof 6